IBDEI0N3 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11358,1,2,0)
 ;;=2^99239
 ;;^UTILITY(U,$J,358.3,11359,0)
 ;;=188.9^^76^748^5
 ;;^UTILITY(U,$J,358.3,11359,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11359,1,1,0)
 ;;=1^188.9
 ;;^UTILITY(U,$J,358.3,11359,1,2,0)
 ;;=2^BLADDER CANCER
 ;;^UTILITY(U,$J,358.3,11359,2)
 ;;=^267253
 ;;^UTILITY(U,$J,358.3,11360,0)
 ;;=162.9^^76^748^25
 ;;^UTILITY(U,$J,358.3,11360,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11360,1,1,0)
 ;;=1^162.9
 ;;^UTILITY(U,$J,358.3,11360,1,2,0)
 ;;=2^LUNG CANCER
 ;;^UTILITY(U,$J,358.3,11360,2)
 ;;=^73521
 ;;^UTILITY(U,$J,358.3,11361,0)
 ;;=191.9^^76^748^7
 ;;^UTILITY(U,$J,358.3,11361,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11361,1,1,0)
 ;;=1^191.9
 ;;^UTILITY(U,$J,358.3,11361,1,2,0)
 ;;=2^BRAIN CANCER
 ;;^UTILITY(U,$J,358.3,11361,2)
 ;;=^267279
 ;;^UTILITY(U,$J,358.3,11362,0)
 ;;=171.9^^76^748^50
 ;;^UTILITY(U,$J,358.3,11362,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11362,1,1,0)
 ;;=1^171.9
 ;;^UTILITY(U,$J,358.3,11362,1,2,0)
 ;;=2^SARCOMAS/OTH SOFT TISSUE CANCER
 ;;^UTILITY(U,$J,358.3,11362,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,11363,0)
 ;;=150.9^^76^748^16
 ;;^UTILITY(U,$J,358.3,11363,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11363,1,1,0)
 ;;=1^150.9
 ;;^UTILITY(U,$J,358.3,11363,1,2,0)
 ;;=2^ESOPHAGEAL CANCER
 ;;^UTILITY(U,$J,358.3,11363,2)
 ;;=^267055
 ;;^UTILITY(U,$J,358.3,11364,0)
 ;;=153.9^^76^748^15
 ;;^UTILITY(U,$J,358.3,11364,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11364,1,1,0)
 ;;=1^153.9
 ;;^UTILITY(U,$J,358.3,11364,1,2,0)
 ;;=2^COLON CANCER
 ;;^UTILITY(U,$J,358.3,11364,2)
 ;;=^267078
 ;;^UTILITY(U,$J,358.3,11365,0)
 ;;=152.9^^76^748^55
 ;;^UTILITY(U,$J,358.3,11365,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11365,1,1,0)
 ;;=1^152.9
 ;;^UTILITY(U,$J,358.3,11365,1,2,0)
 ;;=2^SMALL INTESTINE CANCER
 ;;^UTILITY(U,$J,358.3,11365,2)
 ;;=^267077
 ;;^UTILITY(U,$J,358.3,11366,0)
 ;;=193.^^76^748^60
 ;;^UTILITY(U,$J,358.3,11366,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11366,1,1,0)
 ;;=1^193.
 ;;^UTILITY(U,$J,358.3,11366,1,2,0)
 ;;=2^THYROID CANCER
 ;;^UTILITY(U,$J,358.3,11366,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,11367,0)
 ;;=284.9^^76^748^3
 ;;^UTILITY(U,$J,358.3,11367,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11367,1,1,0)
 ;;=1^284.9
 ;;^UTILITY(U,$J,358.3,11367,1,2,0)
 ;;=2^APLASTIC ANEMIA NOS
 ;;^UTILITY(U,$J,358.3,11367,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,11368,0)
 ;;=170.9^^76^748^6
 ;;^UTILITY(U,$J,358.3,11368,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11368,1,1,0)
 ;;=1^170.9
 ;;^UTILITY(U,$J,358.3,11368,1,2,0)
 ;;=2^BONE AND CARTILAGE CANCER
 ;;^UTILITY(U,$J,358.3,11368,2)
 ;;=^267155
 ;;^UTILITY(U,$J,358.3,11369,0)
 ;;=175.9^^76^748^9
 ;;^UTILITY(U,$J,358.3,11369,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11369,1,1,0)
 ;;=1^175.9
 ;;^UTILITY(U,$J,358.3,11369,1,2,0)
 ;;=2^BREAST CANCER-MALE
 ;;^UTILITY(U,$J,358.3,11369,2)
 ;;=^267205
 ;;^UTILITY(U,$J,358.3,11370,0)
 ;;=209.10^^76^748^10
 ;;^UTILITY(U,$J,358.3,11370,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11370,1,1,0)
 ;;=1^209.10
 ;;^UTILITY(U,$J,358.3,11370,1,2,0)
 ;;=2^CARCINOID, LARGE INTESTINE
 ;;^UTILITY(U,$J,358.3,11370,2)
 ;;=^336722
 ;;^UTILITY(U,$J,358.3,11371,0)
 ;;=209.29^^76^748^11
 ;;^UTILITY(U,$J,358.3,11371,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11371,1,1,0)
 ;;=1^209.29
 ;;^UTILITY(U,$J,358.3,11371,1,2,0)
 ;;=2^CARCINOID,NONBOWEL AND OTH SITE
 ;;^UTILITY(U,$J,358.3,11371,2)
 ;;=^336507
 ;;^UTILITY(U,$J,358.3,11372,0)
 ;;=209.00^^76^748^12
 ;;^UTILITY(U,$J,358.3,11372,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11372,1,1,0)
 ;;=1^209.00
 ;;^UTILITY(U,$J,358.3,11372,1,2,0)
 ;;=2^CARCINOID,SMALL INTESTINE
